Ptc Therapeutics (PTCT) Profit After Tax (2012 - 2026)

Ptc Therapeutics' Profit After Tax history runs 15 years deep, the most recent figure standing at -$2.8 million for Q1 2026.

• In Q1 2026, Profit After Tax fell 100.32% year-over-year to -$2.8 million; the TTM figure through Mar 2026 stood at -$186.7 million (down 131.39% YoY), while the FY2025 annual figure was $682.6 million, up 287.9% from the prior year.
• Profit After Tax was -$2.8 million for Q1 2026 at Ptc Therapeutics, up from -$135.0 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $866.6 million in Q1 2025 to a low of -$198.9 million in Q2 2023.
• Historically, Profit After Tax has averaged -$51.1 million across 5 years, with a median of -$109.3 million in 2022.
• Biggest YoY gain for Profit After Tax was 1046.28% in 2025; the steepest drop was 104.85% in 2025.
• A 5-year view of Profit After Tax shows it stood at -$170.9 million in 2022, then rose by 8.83% to -$155.8 million in 2023, then soared by 57.71% to -$65.9 million in 2024, then tumbled by 104.85% to -$135.0 million in 2025, then surged by 97.92% to -$2.8 million in 2026.
• The last three Profit After Tax figures came in at -$2.8 million (Q1 2026), -$135.0 million (Q4 2025), and $15.9 million (Q3 2025), per Business Quant data.